You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Castration-resistant prostate cancer (CRPC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Seoul ([177Lu]Ludotadipep)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer, mCRPC
  • Seoul, Korea, Republic of
    The Catholic University of Korea, Seoul, St, Mary's Hospital, 22
Dec 8, 2022

Castration Resistant Prostate Cancer, CRPC Trial in Seoul (Cellgram-DC-PC)

Terminated
  • Castration Resistant Prostate Cancer, CRPC
  • Cellgram-DC-PC
  • Seoul, Korea, Republic of
    Asan medical center
Dec 29, 2022

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Sep 18, 2022

Treatment Satisfaction With Ra-223 in Japan

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
Jan 12, 2023

Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • [177Lu]Ludotadipep 3.7 GBq
  • (no location specified)
Jul 12, 2022

How Radium-223 Dichloride,Alpha Particle-emitting Radioactive

Recruiting
  • Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Taiwan
    Many locations
Aug 19, 2022

Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))

Active, not recruiting
Has Results
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
Jan 17, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Prostatic Cancer, Castration-Resistant Trial in United States (Darolutamide(Nubeqa, BAY1841788), Enzalutamide)

Completed
  • Prostatic Cancer, Castration-Resistant
  • Portland, Maine
  • +6 more
Aug 18, 2022

Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)

Active, not recruiting
  • Prostate Cancer
  • Castration Resistant Prostate Cancer
  • San Francisco, California
  • +4 more
Mar 18, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Detroit,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Detroit, Michigan
  • +1 more
Aug 30, 2022

Prostate Cancer Trial in New York (Abiraterone acetate, Prednisone, Radium-223 dichloride)

Completed
  • Prostate Cancer
  • Abiraterone acetate
  • +5 more
  • New York, New York
  • +1 more
Dec 10, 2021

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Castration-resistant Prostate Cancer Trial in Osaka (Enzalutamide, Flutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,

Active, not recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Abiraterone Acetate
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 23, 2022

Metastatic Castration Resistant Prostate Cancer, 68Ga-PSMA PET/CT Positive Trial in Meldola (177Lu-PSMA)

Unknown status
  • Metastatic Castration Resistant Prostate Cancer
  • 68Ga-PSMA PET/CT Positive
  • Meldola, FC, Italy
    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
Feb 25, 2021

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Apalutamide, Biopsy, Biospecimen Collection)

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 20, 2023

Gather More Information About Bone Fractures and Survival in

Completed
  • Metastatic Castration-Resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Other standard care
  • Database Study, Sweden
    Database Study
Jul 1, 2021

Castration-resistant Prostate Cancer Trial in Wuxi (Coenzyme A Combined With Abiraterone, Abiraterone)

Recruiting
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Apr 8, 2021

Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

Not yet recruiting
  • Prostatic Neoplasm
  • (no location specified)
Apr 27, 2023

Bone Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Recruiting
  • Bone Metastatic Castration-resistant Prostate Cancer
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Linz, Oberösterreich, Austria
  • +15 more
Aug 24, 2022

Castration-Resistant Prostate Cancer Trial in Las Vegas, Port Jefferson Station (Enzalutamide or Abiraterone or Apalutamid)

Recruiting
  • Castration-Resistant Prostate Cancer
  • Enzalutamide or Abiraterone or Apalutamid
  • Las Vegas, Nevada
  • +1 more
Apr 4, 2022

Prostate Cancer Metastatic Trial in Leiden (Enzalutamide, 18-FDG PET/CT, Whole body MRI)

Completed
  • Prostate Cancer Metastatic
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 6, 2022